Violation Detail
Standard Cited: 19101053 J03 I
This violation item has been deleted.
Inspection Nr: 1387638.015
Citation: 03003F
Citation Type: Other
Abatement Status:
Initial Penalty: $0.00
Current Penalty: $0.00
Issuance Date: 08/29/2019
Nr Instances: 1
Nr Exposed: 53
Abatement Date: 09/18/2019
Gravity:
Report ID: 0830600
Contest Date:
Final Order: 09/18/2019
Related Event Code (REC): C
Emphasis:
Substance: 9000
Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
---|---|---|---|---|---|---|
Penalty | I: Informal Settlement | 09/18/2019 | $0.00 | 09/18/2019 | Other | |
Penalty | Z: Issued | 08/29/2019 | $0.00 | 09/18/2019 | Other |
Text For Citation: 03 Item/Group: 003F Hazard:
29 CFR 1910.1053(j)(3)(i): The employer did not ensure that each employee covered by this section could demonstrate knowledge and understanding of the following: (A) the health hazards associated with exposure to respirable crystalline silica; (B) specific tasks in the workplace that could result in exposure to respirable crystalline silica; (C) specific measures the employer has implemented to protect employees from exposure to respirable crystalline silica, including engineering controls, work practices, and respirators to be used; (D) the contents of this section; and, (E) the purpose and a description of the medical surveillance program required by paragraph (i) of this section: (a) On or about March 5, 2019, and at times prior, the employer did not ensure that employees exposed to respirable crystalline silica from conducting specific artificial stone manufacturing operations could demonstrate knowledge and understanding of the health hazards associated to crystalline silica and the tasks that could result in respirable crystalline silica exposure. This condition exposed employees to the physical hazards of respirable crystalline silica that may result in an increased risk of developing serious silica-related disease, including: Silicosis, lung cancer, chronic obstructive pulmonary disease (COPD), and kidney disease. Abatement Note: Abatement certification is required for this item (see enclosed "Certification of Corrective Action Worksheet")